All News #Library
Rare Diseases
FDA Grants Orphan Drug Designation To Cellectis` CLLS52 For ALL
01 Aug 2024 //
GLOBENEWSWIRE
FDA Grants Orphan And Rare Pediatric Status To Cellectis` UCART22 For ALL
25 Jul 2024 //
GLOBENEWSWIRE
Cellectis gets European orphan drug designation for its candidate UCART22
06 Jun 2024 //
PHARMABIZ

Market Place
Sourcing Support